Biolibra Formulations Private Limited - Company Profile

It is a chemicals private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2011.
2011 Visakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Biolibra Formulations Private Limited

Biolibra Formulations Private Limited, a active private limited company, was established on 25 October 2011 in Visakhapatnam, Andhra Pradesh, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U24232AP2011PTC077149. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.43 M.

It upholds a compliant status. Its leadership includes Chandan Sai Kumar Golagani (Additional Director), Rishi Ram Kumar Golagani (Additional Director). Past directors included Golagani Aruna Jyothi, Ashok Kumar Golagani, Sathya Venkata Durga Nagendra Kumar Botta. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Plot No.17A, Health City China Gadili, Visakhapatnam, Andhra Pradesh, 530040.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232AP2011PTC077149

  • Registration Number

    077149

  • Incorporation Date

    25 October 2011

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.43 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.43 M
  • Company Age 14 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets **** 3.30%
Company report

Biolibra Formulations Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biolibra Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Biolibra Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandan Sai Kumar Golagani Additional Director 20 Jun 2025 Current
Rishi Ram Kumar Golagani Additional Director 20 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Jun 2025 Past
Pramod Abcsdd Director 26 Jun 2025 Past
Pramod Abcsdd Director 27 Dec 2013 Past
Pramod Abcsdd Director 27 Dec 2013 Past
Pramod Abcsdd Director 26 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biolibra Formulations.

Biolibra Formulations Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Biolibra Formulations revenue growth over time
Biolibra Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 3.30%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biolibra Formulations?

In 2017, Biolibra Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Biolibra Formulations?

Unlock and access historical data on people associated with Biolibra Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biolibra Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolibra Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biolibra Formulations
Recent Activity within the Organization
  • Director Appointment

    The activity Chandan Sai Kumar Golagani was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2025 & has been associated with this company since 8 months 13 days . was completed.

  • Director Appointment

    Progress on Rishi Ram Kumar Golagani was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2025 & has been associated with this company since 8 months 13 days . was documented.

  • Annual General Meeting

    Progress on Biolibra Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Biolibra Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Vijayawada. was documented.

  • Company Incorporation

    The activity Biolibra Formulations Private Limited was registered on 25 Oct 2011 with Roc Vijayawada & aged 14 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biolibra Formulations Private Limited?

The CIN of Biolibra Formulations Private Limited is U24232AP2011PTC077149.

Where is Biolibra Formulations Private Limited headquartered?

Biolibra Formulations Private Limited is headquartered at Plot No.17A, Health City China Gadili, Visakhapatnam, Andhra Pradesh, 530040.

When was Biolibra Formulations Private Limited incorporated?

Biolibra Formulations Private Limited was incorporated on 25 October 2011.

Who are the current directors of Biolibra Formulations Private Limited?

The current directors of Biolibra Formulations Private Limited are

What is the primary industry of Biolibra Formulations Private Limited?

The primary industry of Biolibra Formulations Private Limited is Manufacturing.

Is Biolibra Formulations Private Limited a listed company?

Biolibra Formulations Private Limited is unlisted.

What is the capital structure of Biolibra Formulations Private Limited?

The authorized capital of Biolibra Formulations Private Limited is ₹0.50 M, and the paid-up capital is ₹0.43 M.

What is the compliance status of Biolibra Formulations Private Limited?

The compliance status of Biolibra Formulations Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available